Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

sickle-in-africa/outcome-of-hydroxyurea-use

Domaine:

healthcare
Créateur:
sic
Hôte:
R scripts for the Frontiers publication *Outcome of Hydroxyurea Use in SCD and Evaluation of Patients’ Perception and Experience in Nigeria* # Outcome of Hydroxyurea Use in SCD and Evaluation of Patients’ Perception and Experience in Nigeria R scripts for the Frontiers publication frontiersin.org

Visit

github.com

Licenses

GPL-3.0

Similaires

Outcome of Hydroxyurea Use in SCD and Evaluation of Patients’ Perception and Experience in NigeriaDeterminants of hydroxyurea use among doctors, nurses and sickle cell disease patients in NigeriaNutritional Status and Hydroxyurea Use Among Children with Sickle Cell Disease in MalawiThe Impact of Hydroxyurea Use on Cognitive Functioning of Children with Sickle Cell Disease in GhanaEvaluation of The Use of Hydroxyurea in Treating Children With Sickle Cell Anemia in Central Africa's Rural AreaSplenomegaly in Children with Sickle Cell Anemia Receiving Hydroxyurea in Sub-Saharan Africa

Outcome of Hydroxyurea Use in SCD and Evaluation of Patients’ Perception and Experience in Nigeria

Introduction: Hydroxyurea (HU) has been shown to be beneficial in the management of sickle cell dis

Determinants of hydroxyurea use among doctors, nurses and sickle cell disease patients in Nigeria

Background Hydroxyurea (HU) is an evidence-based therapy that is currently the most effective drug

Nutritional Status and Hydroxyurea Use Among Children with Sickle Cell Disease in Malawi

Abstract Introduction: The global distribution of sickle cell dise

The Impact of Hydroxyurea Use on Cognitive Functioning of Children with Sickle Cell Disease in Ghana

Introduction: Sickle cell disease (SCD) is a genetic blood disorder characterized by a mutated hemog

Evaluation of The Use of Hydroxyurea in Treating Children With Sickle Cell Anemia in Central Africa's Rural Area

ABSTRACT Background Sickle cell anem

Splenomegaly in Children with Sickle Cell Anemia Receiving Hydroxyurea in Sub-Saharan Africa

Introduction. Children with sickle cell anemia enrolled in Realizing Effectiveness Across Continents